Your browser doesn't support javascript.
loading
VGAEDTI: drug-target interaction prediction based on variational inference and graph autoencoder.
Zhang, Yuanyuan; Feng, Yinfei; Wu, Mengjie; Deng, Zengqian; Wang, Shudong.
Afiliação
  • Zhang Y; Yinfei Feng Qingdao University of Technology, Qingdao, China.
  • Feng Y; Yinfei Feng Qingdao University of Technology, Qingdao, China. fyf777773@163.com.
  • Wu M; Yinfei Feng Qingdao University of Technology, Qingdao, China.
  • Deng Z; Yinfei Feng Qingdao University of Technology, Qingdao, China.
  • Wang S; School of Computer Science and Technology, China University of Petroleum, Qingdao, China.
BMC Bioinformatics ; 24(1): 278, 2023 Jul 06.
Article em En | MEDLINE | ID: mdl-37415176
ABSTRACT
MOTIVATION Accurate identification of Drug-Target Interactions (DTIs) plays a crucial role in many stages of drug development and drug repurposing. (i) Traditional methods do not consider the use of multi-source data and do not consider the complex relationship between data sources. (ii) How to better mine the hidden features of drug and target space from high-dimensional data, and better solve the accuracy and robustness of the model.

RESULTS:

To solve the above problems, a novel prediction model named VGAEDTI is proposed in this paper. We constructed a heterogeneous network with multiple sources of information using multiple types of drug and target dataIn order to obtain deeper features of drugs and targets, we use two different autoencoders. One is variational graph autoencoder (VGAE) which is used to infer feature representations from drug and target spaces. The second is graph autoencoder (GAE) propagating labels between known DTIs. Experimental results on two public datasets show that the prediction accuracy of VGAEDTI is better than that of six DTIs prediction methods. These results indicate that model can predict new DTIs and provide an effective tool for accelerating drug development and repurposing.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reposicionamento de Medicamentos / Desenvolvimento de Medicamentos Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reposicionamento de Medicamentos / Desenvolvimento de Medicamentos Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article